Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CBAY

CymaBay

$12.25

0.54 (4.61%)

08:12
02/13/18
02/13
08:12
02/13/18
08:12
Initiation
CymaBay initiated at Evercore ISI »

CymaBay initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

CBAY

CymaBay

$12.25

0.54 (4.61%)

, CPRX

Catalyst Pharmaceuticals

$3.37

0.095 (2.90%)

07:50
02/13/18
02/13
07:50
02/13/18
07:50
Conference/Events
SunTrust to hold a conference »

2018 Orphan Drug Day to…

CBAY

CymaBay

$12.25

0.54 (4.61%)

CPRX

Catalyst Pharmaceuticals

$3.37

0.095 (2.90%)

DRNA

Dicerna

$9.33

0.02 (0.21%)

EDIT

Editas Medicine

$32.85

-0.84 (-2.49%)

MGNX

MacroGenics

$22.72

0.06 (0.26%)

MRUS

Merus

$16.33

0.26 (1.62%)

ONCE

Spark Therapeutics

$54.08

1.53 (2.91%)

QURE

uniQure

$22.32

3.15 (16.43%)

RGNX

Regenxbio

$26.75

1.05 (4.09%)

SMMT

Summit Therapeutics

$10.80

0.2 (1.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

  • 21

    Feb

  • 26

    Feb

  • 04

    Apr

CBAY

CymaBay

$11.29

-0.35 (-3.01%)

08:11
01/30/18
01/30
08:11
01/30/18
08:11
Syndicate
CymaBay 11.6M share Spot Secondary priced at $10.80 »

Leerink and Evercore ISI…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

CBAY

CymaBay

$11.29

-0.35 (-3.01%)

16:45
01/29/18
01/29
16:45
01/29/18
16:45
Syndicate
CymaBay files to sell common stock, no amount given »

Leerink Partners and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBAY

CymaBay

$11.69

0.96 (8.95%)

08:29
01/25/18
01/25
08:29
01/25/18
08:29
Initiation
CymaBay initiated at Roth Capital »

CymaBay assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBAY

CymaBay

07:12
01/24/18
01/24
07:12
01/24/18
07:12
Recommendations
CymaBay analyst commentary at H.C. Wainwright »

CymaBay price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$80.68

2.12 (2.70%)

, PTLA

Portola Pharmaceuticals

$49.63

-0.06 (-0.12%)

07:37
01/22/18
01/22
07:37
01/22/18
07:37
Recommendations
Neurocrine, Portola Pharmaceuticals, CymaBay analyst commentary at Oppenheimer »

Neurocrine, CymaBay could…

NBIX

Neurocrine

$80.68

2.12 (2.70%)

PTLA

Portola Pharmaceuticals

$49.63

-0.06 (-0.12%)

CBAY

CymaBay

$10.20

0.06 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 02

    Feb

  • 08

    Mar

  • 04

    May

Over a month ago
CBAY

CymaBay

$9.69

-0.21 (-2.12%)

08:32
01/08/18
01/08
08:32
01/08/18
08:32
Hot Stocks
CymaBay receives $5M milestone payment from Kowa Pharmaceuticals »

CymaBay Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

  • 08

    Jan

CBAY

CymaBay

$9.20

0.15 (1.66%)

17:08
12/29/17
12/29
17:08
12/29/17
17:08
Syndicate
Breaking Syndicate news story on CymaBay »

CymaBay files $200M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

CBAY

CymaBay

$8.71

0.13 (1.52%)

08:17
11/28/17
11/28
08:17
11/28/17
08:17
Recommendations
CymaBay analyst commentary at Leerink »

Survey suggests CymaBay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 29

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.